BioInnovations

adMare BioInnovations is a leading Canadian life sciences innovation hub and venture builder dedicated to identifying and developing promising therapeutic research into scalable, globally competitive companies. By providing specialized R&D infrastructure, commercial expertise, and seed capital, adMare bridges the gap between academic discovery and clinical-stage commercialization. The organization maintains an internal pipeline of drug development projects and has successfully helped build over 35 companies, including notable spin-outs like Kairos Therapeutics and Abdera Therapeutics. With innovation centers in Montreal and Vancouver, adMare serves as a critical anchor for the Canadian biotech ecosystem, fostering talent and driving the development of next-generation therapies in oncology, neurology, and precision medicine.